Table 5.
Relationship between mGPS and therapy-related toxicities
| Toxicities (CTC) ≥ grade 2 | mGPS 0 (n = 51), n (%) | mGPS 1 (n = 70), n (%) | mGPS 2 (n = 35), n (%) | p value |
|---|---|---|---|---|
| Anemia | 5 (9) | 24 (34) | 21 (60) | <0.01** |
| Neutropenia | 6 (12) | 32 (46) | 30 (86) | <0.01** |
| Nausea/emesis | 8 (16) | 25 (36) | 23 (74) | <0.01** |
| Anorexia | 8 (16) | 26 (37) | 21 (60) | <0.01** |
| Mucositis | 3 (6) | 7 (10) | 12 (34) | <0.05 |
| Fatigue | 9 (18) | 21 (30) | 17 (49) | <0.01** |
| Neurotoxicity | 4 (8) | 10 (14) | 15 (43) | <0.01** |
mGPS, modified Glasgow Prognostic Score.
**
Indicates statistical significance.